The VICC.ORG Directory of Doctors, Healthcare Providers & Researchers

George C. Hill, Ph.D.

Associate Dean for Diversity
VICC Member
Researcher

Contact Information:

Vanderbilt University Medical Center
301 Light Hall
Nashville, TN 37232
615-322-7498

Research Specialty

Molecular and biochemical basis of differentiation and characterization of the trypanosome alternative oxidase in African trypanosomes, the causative agent of African trypanosomiasis.

Research Description

Trypanosoma brucei is the causative agent of African trypanosomiasis and is a re-emerging infection in sub-Sahara Africa. In both the bloodstream and insect vector stages, there is a unique cyanide insensitive, salicylhydroxamic acid (SHAM) sensitive alternative oxidase that is expressed. This trypanosome alternative oxidase (TAO) is the only oxidase present in the bloodstream forms. However, in addition to the TAO, the procyclic trypanosomes contain an established cytochrome system. Our laboratory has characterized the electron transport systems in both systems.

We have identified the TAO as a potential target for trypanocidal drugs and begun to synthesize compounds that inhibit the TAO in vitro and in vivo. In the bloodstream stages, this unique cyanide insensitive, salicylhydroxamic acid (SHAM) sensitive alternative oxidase is expressed as the only oxidase present in the bloodstream forms. RNA interference (RNAi) studies have been performed that demonstrate that the TAO is essential for survival. RNAi plasmid constructs using p2T7ti_B/GFP were made, linearized and transfected into T. brucei 427 bloodstream trypomastigotes. After transfection, selection, and induction, the TAO message in bloodstream transfectants was markedly reduced in the presence of tetracycline after 48 hours. Importantly, immunoblot analysis revealed that there was also approximately a 1.5 fold decrease in the TAO protein level in these bloodstream cells after RNAi induction. In vivo studies revealed that there was a five-fold reduction in the parasitemia levels in RNAi induced mice and rats infected with T. brucei RNAi-transfected cells and their life was extended, clearly demonstrating the proof of principal that the TAO can serve as an effective target for trypanocidal drugs. There was also a five-fold reduction in the TAO protein level isolated from parasites infected in RNAi induced mice as compared to the control. Additionally, respiration assays of RNAi-transfected T. brucei isolated from rats revealed that there was 100% SHAM inhibition in cells induced with tetracycline.

The prenylated salicylic acid derived substructural motif is the key chemical and/or structural feature important for inhibition of TAO within the limited series of exploratory compounds we have investigated. It has also been demonstrated that synthesizing carbohydrate-linked analogs improves solubility properties. Further testing of compounds in this category is being pursued as well as studies testing the effectiveness of these compounds in laboratory models of trypanosomiasis.

Current efforts are also being devoted to the purification of the TAO and subsequent crystallization of this essential enzyme in African trypanosomes, the causative agent of African sleeping sickness.

Major Collaborators:

Minu Chaudhuri, Ph.D. - Meharry Medical College, Department of Microbiology, Nashville, TN

Kelly Chibale, Ph.D. - University of Cape Town, Department of Chemistry, Cape Town, South Africa

Publications


You do not have JavaScript enabled. This site works better with JavaScript turned on.